Oncology Central

Vaccine success for cervical cancer: study reports fall in HPV infections

0
Since the introduction of the HPV vaccine in England in 2008, Public Health England (PHE; London, UK) have reported an 86% decrease in HPV infections in women aged 16–21. With these promising results, experts predict that the vaccine could eventually lead to the eradication of cervical cancer.
To view restricted content, please:
Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.